The discourse of karma.
It seems logical that in the ritual process of mortifying the body of a dying person, the proto-Sramanas realised that the mental processes also needed to be mortified. Both the body and the mind needed to be prepared for the moment of death in order to secure a correct and beneficial slide into death. How could one prepare the mind for death?
The mind was perceived as one of the human senses. Mind and senses belonged to prakriti, which by definition meant they were in perpetual movement.
I-Want-It-So-Badly Meditation Photos
Click to Photo for Next Images of I-Want-It-So-Badly Meditation
A new aim of austerity became not only to stop the movements and processes of the body but also the thoughts and feelings constantly emerging in consciousness. Meditation became a tool in relation to develop a still mind' – a specific altered state of consciousness (ASC) very similar to death. We could say that meditation for the Sramanas became a new kind of ascese' (an austere exertion) directed towards the mind's death. Bronkhorst introduces the term mortification of the mind' to describe this specific kind of asceticism of the mind called meditation.
But why did the individual need to stop the ever-fluctuating mind before dying? This is where the sign karma enters. The karma sign gives meaning to why a calm mind is required before dying. So first – what does the sign mean?
Nevertheless, caution should be exercised when using ginkgo in patients I-Want-It-So-Badly Meditation on anticoagulants, and gingko should be discontinued two weeks prior to surgery. G. biloba I-Want-It-So-Badly Meditation extract has neuroprotective effects and benefits for memory, age-associated memory impairment, vascular dementia, and Alzheimer's. In a DBRPC multicenter 52-week study of 236 patients with Alzheimer's, G. Biloba extract EGb 761 120 mg/day improved cognitive performance in patients with mild to moderate cognitive impairment and also slowed the deterioration in patients with severe impairment Le Bars, Velasco, Ferguson, Dessain, Kieser, et al. 2002. A DBRPC comparison study of 109 schizophrenic patients found that patients given Haldol plus EGb 360 mg/day had significant reductions in Scales for Assessment of Negative Symptoms and Positive Symptoms compared to patients treated with haloperidol only. In addition, the EGb-treated group had fewer extrapyramidal side effects.